Dr. Rutrick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
521 Mount Auburn St Ste 107-109
Watertown, MA 02472Phone+1 617-775-1818Fax+1 617-744-8543
Education & Training
SUNY Upstate Medical UniversityResidency, Psychiatry, 1972 - 1974- SUNY Upstate Medical UniversityInternship, Transitional Year, 1971 - 1972
SUNY Upstate Medical UniversityClass of 1971
Certifications & Licensure
MA State Medical License 1974 - 2025
NY State Medical License 1972 - 2025- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder Start of enrollment: 2015 Jul 27
Publications & Presentations
PubMed
- 3 citations18-Month efficacy and safety analysis of monthly subcutaneous buprenorphine injection for opioid use disorder: Integrated analysis of phase 3 studies.Daniel Rutrick, Susan M Learned, Brent Boyett, David Hassman, Sunita Shinde
Journal of Substance Use and Addiction Treatment. 2023-11-01 - 21 citationsTreating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis.Anne Andorn, Barbara R. Haight, Sunita Shinde, Paul J. Fudala, Y Zhao
Journal of Clinical Psychopharmacology. 2020-05-01 - 23 citationsMavoglurant Augmentation in OCD Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Proof-of-Concept, Randomized, Placebo-Controlled, Phase 2 Study.Daniel Rutrick, Dan J. Stein, Ganesan Subramanian, Brian Smith, Maurizio Fava
Advances in Therapy. 2017-01-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
